Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended 30.09.2025 along with Limited Review Report.
BI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bilcare reported a mixed set of numbers for Q2 FY26. On a standalone basis, revenue from operations fell sharply to Rs 1.85 crore (vs Rs 2.76 crore in Q2 FY25), though the company swung to a profit of Rs 1.04 crore from a loss of Rs 2.57 crore, supported by other income and lower finance costs. On a consolidated basis, revenue declined to Rs 178.20 crore in Q2 (from Rs 201.74 crore) and Rs 364.56 crore for H1 FY26 (from Rs 395.88 crore). The group continued to post losses at the consolidated level, though narrower — Rs 23.32 crore in Q2 (vs Rs 29.93 crore) and Rs 33.08 crore for H1 (vs Rs 44.95 crore). The statutory auditor issued a qualified review report, flagging that Rs 13.78 crore of penal interest on a CSIR loan should have been booked as a provision rather than a contingent liability, and that the loan should be reclassified as current. The auditor also highlighted material uncertainty around the company's ability to continue as a going concern due to historical operating losses, contingent on the success of the GCS business strategy.
Shareholders should note the auditor's qualified opinion, explicit going-concern uncertainty, and ongoing legal matters (SFIO investigation, CSIR loan dispute, public fixed deposit liabilities of Rs 45.33 crore). While standalone turned profitable, the consolidated business remains loss-making, and the shift of auditor from Sharp & Tannan (who reviewed Q1) to Patki & Soman may attract attention. Stock could remain volatile given the unresolved contingencies and weak operating performance.